Is Ketamine Metabolism to Norketamine and (2R,6R)-HNK Necessary for its Sustained Antidepres-sant-Like Activity and Cortical Neurotransmitter Release in Mice?

被引:0
|
作者
Thi Mai Loan Nguyen [1 ]
Defaix, Celine [1 ]
Mendez-David, Indira [1 ]
Thu Ha Pham [1 ]
Guilloux, Jean-Philippe [2 ]
Etting, Isabelle [3 ]
Alvarez, Jean-Claude [3 ]
McGowan, Josephine C. [4 ]
David, Denis J. [1 ]
Denny, Christine A. [4 ]
Gardier, Alain [1 ]
机构
[1] Univ Paris Sud, Orsay, France
[2] Univ Paris Sud, CESP, UMRS1178, Chatenay Malabry, France
[3] Ctr Hosp Univ R Poincare, Garches, France
[4] Columbia Univ, New York, NY 10027 USA
关键词
Ketamine; Antidepressant; CYP Inhibitor; Glutamate Release; BALB/Cj Mice;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
S136
引用
收藏
页码:S349 / S349
页数:1
相关论文
共 37 条
  • [31] Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit
    N Yao
    O Skiteva
    X Zhang
    P Svenningsson
    K Chergui
    Molecular Psychiatry, 2018, 23 : 2066 - 2077
  • [32] What role does the (2R,6R)-hydronorketamine metabolite play in the antidepressant-like and abuse-related effects of (R)-ketamine?
    Hillhouse, Todd M.
    Rice, Remington
    Porter, Joseph H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (19) : 3886 - 3888
  • [33] Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model
    Xiong, Zhongwei
    Fujita, Yuko
    Zhang, Kai
    Pu, Yaoyu
    Chang, Lijia
    Ma, Min
    Chen, Jincao
    Hashimoto, Kenji
    BEHAVIOURAL BRAIN RESEARCH, 2019, 368 : 176 - 182
  • [34] What role does the (2R,6R)-hydronorketamine metabolite play in the antidepressant-like and abuse-related effects of (R)-ketamine? (vol 176, pg 3886, 2019)
    Hillhouse, T. M.
    Rice, R.
    Porter, J. H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (14) : 3357 - 3357
  • [35] (2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray
    Chou, Dylan
    Peng, Hsien-Yu
    Lin, Tzer-Bin
    Lai, Cheng-Yuan
    Hsieh, Ming-Chun
    Wen, Yang-Cheng
    Lee, An-Sheng
    Wang, Hsueh-Hsiao
    Yang, Po-Sheng
    Chen, Gin-Den
    Ho, Yu-Cheng
    NEUROPHARMACOLOGY, 2018, 139 : 1 - 12
  • [36] Ketamine and its metabolite 2R,6R-hydroxynorketamine promote ocular dominance plasticity and release tropomyosin-related kinase B from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneurons
    Cannarozzo, Cecilia
    Rubiolo, Anna
    Casarotto, Plinio
    Castren, Eero
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2023, 57 (06) : 940 - 950
  • [37] Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371•HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like Activity
    Chappell, Mark D.
    Li, Renhua
    Smith, Stephon C.
    Dressman, Bruce A.
    Tromiczak, Eric G.
    Tripp, Allie E.
    Blanco, Maria-Jesus
    Vetman, Tatiana
    Quimby, Steven J.
    Matt, James
    Britton, Thomas C.
    Fivush, Adam M.
    Schkeryantz, Jeffrey M.
    Mayhugh, Daniel
    Erickson, Jon A.
    Bures, Mark G.
    Jaramillo, Carlos
    Carpintero, Mercedes
    Eugenio de Diego, Jose
    Barberis, Mario
    Garcia-Cerrada, Susana
    Soriano, Jose F.
    Antonysamy, Stephen
    Atwell, Shane
    MacEwan, Lain
    Condon, Bradley
    Sougias, Christine
    Wang, Jing
    Zhang, Aiping
    Conners, Kris
    Groshong, Chris
    Wasserman, Stephen R.
    Koss, John W.
    Witkin, Jeffrey M.
    Li, Xia
    Overshiner, Carl
    Wafford, Keith A.
    Seidel, Wesley
    Wang, Xu-Shan
    Heinz, Beverly A.
    Swanson, Steven
    Catlow, John T.
    Bedwell, David W.
    Monn, James A.
    Mitch, Charles H.
    Ornstein, Paul L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (24) : 10974 - 10993